RIBOVAX BIOTECHNOLOGIES S A has a total of 15 patent applications. Its first patent ever was published in 2006. It filed its patents most often in Israel, Australia and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ARMAGEN TECHNOLOGIES INC, IMMUNEONCO BIOPHARMACEUTICALS SHANGHAI CO LTD and ABCLON INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Israel | 6 | |
#2 | Australia | 2 | |
#3 | United States | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Enzymes | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Burioni Roberto | 7 |
#2 | Clementi Massimo | 7 |
#3 | Landolfo Santo | 1 |
#4 | Roberto Burioni | 1 |
#5 | Massimo Clementi | 1 |
#6 | Gribaudo Giorgio | 1 |
#7 | Funaro Ada | 1 |
Publication | Filing date | Title |
---|---|---|
WO2008107187A1 | Antibodies specific for rubella virus |